Robin L. Gal

4.5k citations

74 papers · 2.0k indexed · h-index 26

Impact in

Ophthalmology top 0.5%
- Glaucoma and retinal disorders
Radiology, Nuclear Medicine and Imaging top 1%
- Corneal surgery and disorders
- Corneal Surgery and Treatments

Papers in

Endocrinology, Diabetes and Metabolism 43
- Diabetes Management and Research 40
- Diabetes Treatment and Management 14
Ophthalmology 21
- Glaucoma and retinal disorders 11
- Retinal and Optic Conditions 7

Co-authors: Roy W. Beck Edward J. Holland Mark J. Mannis Jonathan H. Lass Mariya Dontchev Alan Sugar Steven M. Willi Craig Kollman
Journals: Diabetes Technology & Therapeutics (7 papers)Cornea (7 papers)Diabetes (6 papers)Ophthalmology (5 papers)JAMA Ophthalmology (4 papers)
Partner nations: United States Canada Saudi Arabia

In The Last Decade

Robin L. Gal

70 papers receiving 1.9k citations

Peers

Countries citing papers authored by Robin L. Gal

Since Specialization

Citations

This map shows the geographic impact of Robin L. Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Gal more than expected).

Fields of papers citing papers by Robin L. Gal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Gal. The network helps show where Robin L. Gal may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin L. Gal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin L. Gal Line = papers co-authored together Robin L. Gal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort Diabetologia ·Andrew Morin, Fatou Sakho, Robin L. Gal, Peter Calhoun, Zoey Li, Peter G. Jacobs, Mark A. Clements, Corby K. Martin, Francis J. Doyle, Susana R. Patton, Jessica R. Castle, Melanie B. Gillingham, Roy W. Beck, Michael R. Rickels, Michael C. Riddell, (unknown)	2024	2
2	Online Classification of Unstructured Free-Living Exercise Sessions in People with Type 1 Diabetes Diabetes Technology & Therapeutics ·L I Wei, Eleonora M. Aiello, Sunghyun Cho, Michael C. Riddell, Robin L. Gal, Corby K. Martin, Susana R. Patton, Michael R. Rickels, Francis J. Doyle	2024	1
3	Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study The Journal of Clinical Endocrinology & Metabolism ·Aulo Persio Flaco, Zoey Li, Robin L. Gal, Jessica R. Castle, Francis J. Doyle, Peter G. Jacobs, Corby K. Martin, Roy W. Beck, Peter Calhoun, Michael C. Riddell, Michael R. Rickels	2024	2
4	Patient-Reported Outcomes Improve with a Virtual Diabetes Care Model that Includes Continuous Glucose Monitoring Telemedicine Journal and e-Health ·Korey K. Hood, Richard M. Bergenstal, Terra Cushman, Robin L. Gal, Dan Raghinaru, Davida Kruger, Mary L. Johnson, Teresa McArthur, Amy D. Bradshaw, Beth A. Olson, Sean M. Oser, Tamara K. Oser, Craig Kollman, Ruth S. Weinstock, Roy W. Beck, Grazia Aleppo	2024	1
5	Duration of physical activity required to Ameliorate hyperglycemia without causing hypoglycemia in type 1 diabetes: A T1DEXI adults and pediatric cohort analyses Diabetes Research and Clinical Practice ·John Pemberton, Zoey Li, Robin L. Gal, Andrew Morin, Sarah Berten, Peter Calhoun, Michael C. Riddell	2024	1
6	Predicting Hypoglycemia and Hyperglycemia Risk During and After Activity for Adolescents with Type 1 Diabetes Diabetes Technology & Therapeutics ·Sarah Berten, Michael C. Riddell, Robin L. Gal, Susana R. Patton, Mark A. Clements, Jennifer L. Sherr, Peter Calhoun	2024	3
7	The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random Forest Diabetes Technology & Therapeutics ·Sarah Berten, Michael C. Riddell, Peter G. Jacobs, Zoey Li, Robin L. Gal, Mark A. Clements, Francis J. Doyle, Corby K. Martin, Susana R. Patton, Jessica R. Castle, Melanie B. Gillingham, Roy W. Beck, Michael R. Rickels, Peter Calhoun, (unknown)	2023	12
8	Comprehensive Telehealth Model to Support Diabetes Self-Management JAMA Network Open ·Grazia Aleppo, Robin L. Gal, Dan Raghinaru, Davida Kruger, Roy W. Beck, Richard M. Bergenstal, Terra Cushman, Korey K. Hood, Mary L. Johnson, Teresa McArthur, Amy D. Bradshaw, Beth A. Olson, Sean M. Oser, Tamara K. Oser, Craig Kollman, Ruth S. Weinstock	2023	12
9	Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study Pediatric Diabetes ·Risa M. Wolf, Peiyao Cheng, Robin L. Gal, Jonathan Yun Ping Heng, Craig Kollman, Elvira Isganaitis, Sheela N. Magge, Lucy D. Mastrandrea, Georgeanna J. Klingensmith, William V. Tamborlane, Michelle Van Name	2022	3
10	Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC) Diabetes Care ·Fida Bacha, Peiyao Cheng, Robin L. Gal, Jonathan Yun Ping Heng, Craig Kollman, Anne L. Adolph, Ashley H. Shoemaker, Risa M. Wolf, Georgeanna J. Klingensmith, William V. Tamborlane	2021	15
11	More Time in Glucose Range During Exercise Days than Sedentary Days in Adults Living with Type 1 Diabetes Diabetes Technology & Therapeutics ·Michael C. Riddell, Zoey Li, Roy W. Beck, Robin L. Gal, Peter G. Jacobs, Jessica R. Castle, Melanie B. Gillingham, Mark A. Clements, Susana R. Patton, Eyal Dassau, Francis J. Doyle, Corby K. Martin, 任宏锦, Michael R. Rickels	2020	29
12	Assessing Mealtime Macronutrient Content: Patient Perceptions Versus Expert Analyses via a Novel Phone App Diabetes Technology & Therapeutics ·Melanie B. Gillingham, Zoey Li, Roy W. Beck, 任宏锦, Jessica R. Castle, Mark A. Clements, Eyal Dassau, Francis J. Doyle, Robin L. Gal, Peter G. Jacobs, Susana R. Patton, Michael R. Rickels, Michael C. Riddell, Corby K. Martin	2020	19
13	Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model Diabetes Technology & Therapeutics ·Michelle Van Name, Georgeanna J. Klingensmith, Bryce Nelson, Kupper A. Wintergerst, Beckee Garris, Sriman Rakshan, William V. Tamborlane, Mark A. Clements, Tamara S. Hannon, Ashley H. Shoemaker, Jamie Wood, Robin L. Gal	2019	5
14	Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry Pediatric Diabetes ·William V. Tamborlane, Pei-Yao Chang, Craig Kollman, Georgeanna J. Klingensmith, Katrina J. Ruedy, Robin L. Gal, Michelle Van Name, Fida Bacha, Steven M. Willi, Roy W. Beck	2018	11
15	Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries Pediatric Diabetes ·Georgeanna J. Klingensmith, Stefanie Lanzinger, William V. Tamborlane, Sabine E. Hofer, Peiyao Cheng, Carine de Beaufort, Robin L. Gal, Thomas Reinehr, Craig Kollman, Reinhard W. Holl	2018	15
16	Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry Hormone Research in Paediatrics ·Fida Bacha, Peiyao Cheng, Robin L. Gal, Craig Kollman, William V. Tamborlane, Georgeanna J. Klingensmith, R. Berangi, Jamie Wood, Roy W. Beck	2017	20
17	Cornea Preservation Time Study Cornea ·Jonathan H. Lass, Loretta Szczotka‐Flynn, Allison R. Ayala, Beth Ann Benetz, Robin L. Gal, Anthony J. Aldave, F Zampieri, Steven P. Dunn, Diana M Repke, Sudeep Pramanik, George O. D. Rosenwasser, Jonas Le Morvan, Mark A. Terry, David D. Verdier	2015	52
18	Recipient Risk Factors for Graft Failure in the Cornea Donor Study Ophthalmology ·Alan Sugar, Jean Paul Tanner, Mariya Dontchev, Ismail Sissman, Robert L. Schultze, Steven P. Dunn, Thomas D. Lindquist, Robin L. Gal, Roy W. Beck, Craig Kollman, Mark J. Mannis, Edward J. Holland	2009	108
19	Visual function at baseline and 1 month in acute optic neuritis: Predictors of visual outcome Neurology ·Mark J. Kupersmith, Robin L. Gal, Roy W. Beck, Neil R. Miller, New York	2008	6
20	Is Donor Age an Important Determinant of Graft Survival? Cornea ·Roy W. Beck, Robin L. Gal, Mark J. Mannis, Edward J. Holland, 許雅涵, Gary N. Foulks, Ellen Heck, Thomas Lindquist, Marian S. Macsai, Ronald E. Smith, Walter J. Stark, Elmer Y. Tu, Joel Sugar	1999	67

About Robin L. Gal

Robin L. Gal is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology, Genetics, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 74 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (40 papers), Diabetes and associated disorders (21 papers), Corneal surgery and disorders (18 papers), Pancreatic function and diabetes (16 papers), Corneal Surgery and Treatments (15 papers), Diabetes Treatment and Management (14 papers), Glaucoma and retinal disorders (11 papers) and Retinal and Optic Conditions (7 papers). The work is most often cited by research in Ophthalmology (885 citations), Radiology, Nuclear Medicine and Imaging (925 citations), Endocrinology, Diabetes and Metabolism (582 citations), Genetics (333 citations) and Pathology and Forensic Medicine (173 citations). Robin L. Gal has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Roy W. Beck, Edward J. Holland, Mark J. Mannis, Jonathan H. Lass, Mariya Dontchev, Alan Sugar, Steven M. Willi, Craig Kollman, Beth Ann Benetz and Tonya D. Riddlesworth. Their work appears in journals such as Diabetes Technology & Therapeutics, Cornea, Diabetes, Ophthalmology and JAMA Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact